Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Benzimidazole compounds differentiate a mammalian stem cell into mesodermal or cardiomyocyte cells

Benzimidazole compounds differentiate a mammalian stem cell into mesodermal or cardiomyocyte cells

US Patent 9012217 · Granted Apr 21, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cardiogenic mesoderm formation regulators2023
Compounds and matrices for use in bone growth and repair2023
Compounds as inhibitors of sodium channels2022
Compounds and matrices for use in bone growth and repair2020
Chemical and biochemical adducts as biomarkers for organophosphate exposure2020
Epicardial-derived paracrine factors for repairing cardiac tissue2020
Blood brain barrier-penetrating oximes for cholinesterase reactivation2020
Engineered collagen matrices for myocardial therapy2018
Method, system and composition for optically inducing cardiomyocyte contraction2018
Blood brain barrier-penetrating oximes for cholistenerases reactivation2017
Chemical and biochemical adducts as biomarkers for organophosphate exposure2017
Compounds for inhibition of cancer cell proliferation2016